| Literature DB >> 18021895 |
Kamran Ghoreschi1, Christina Weigert, Martin Röcken.
Abstract
Psoriasis is a T cell-dependent autoimmune disease of the skin and joints. Disease manifestation is orchestrated by proinflammatory CD4-positive T helper cells producing either interferon-gamma (Th1) or interleukin (IL)-17 (Th17). These Th1 and Th17 cells interact with dermal dendritic cells, macrophages, mast cells, and neutrophils. Together, they cause an inflammation that mainly involves interferon-gamma, tumor necrosis factor, IL-8, IL-12, IL-17, IL-19, and IL-23. New therapeutics either are directed against T cells, tumor necrosis factor, and IL-12/IL-23 or deviate immune responses into a protective IL-4-dominated Th2 phenotype.Entities:
Mesh:
Substances:
Year: 2007 PMID: 18021895 DOI: 10.1016/j.clindermatol.2007.08.012
Source DB: PubMed Journal: Clin Dermatol ISSN: 0738-081X Impact factor: 3.541